curdlan has been researched along with Leishmaniasis, Visceral in 1 studies
D-hexose : A hexose that has D-configuration at position 5.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
Excerpt | Relevance | Reference |
---|---|---|
"Curdlan was associated with production of the disease-resolving T-helper (Th) 1 and Th17-inducing cytokines interleukin (IL)-6, IL-1β, and IL-23, as well as with production of Th17 cytokines IL-17 and IL-22, as determined by enzyme-linked immunosorbent assay (ELISA) and real time polymerase chain reaction (RT-PCR)." | 1.39 | Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines. ( Das, PK; Ghosh, K; Kar, S; Saha, A; Sharma, G; Ukil, A, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghosh, K | 1 |
Sharma, G | 1 |
Saha, A | 1 |
Kar, S | 1 |
Das, PK | 1 |
Ukil, A | 1 |
1 other study available for curdlan and Leishmaniasis, Visceral
Article | Year |
---|---|
Successful therapy of visceral leishmaniasis with curdlan involves T-helper 17 cytokines.
Topics: Animals; Antibodies, Monoclonal; beta-Glucans; Disease Models, Animal; Immunologic Factors; Interfer | 2013 |